Digital Go To Market

Typically, medical health products compete not only with other services, but also with already existing therapy approaches.

In many healthcare case, the need for therapy is currently increasing, as is openness to digital treatment approaches. This may prompt a large number of established and new competitors to launch their own innovative offerings on the market. In addition, competitors are now competing not only for attention at the point of care, but also in the virtual space. We help manufacturers of digital health products understand their competitors’ moves and provide in-depth analysis on the topics critical for success.

When launching new medical devices, regulatory requirements play a crucial role.

From an outside-in-perspective the German healthcare system appears promising but complex. Depending on the targeted sector (ambulatory care, elderly care or hospitals) very specific regulatory frameworks have evolved over the years. Additionally, a multitude of digitalization programs come on-top with own requirements. Together with a network of sector-specialists, Digital Oxygen guides its local, regional and international clients around common regulatory pitfalls for a successful digital go-to-market.

In many cases there is more than one path to reimbursement – often they can be combined or build on each other.

Currently DiGA is the most prominent market access path followed for digital therapeutics in Germany. However, depending on the company’s vision and mission alternative paths may make more sense (for the moment). The German healthcare system offers various market access opportunities. We help our clients gain clear understanding of the different available paths in terms of benefits, challenges, time-to-market and cost among other relevant aspects. We also give actionable recommendations on where to start and which paths to iteratively leverage for an efficient way into reimbursement.